These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 8786016)

  • 1. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
    Ziegler D; Gries FA
    Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
    Ruhnau KJ; Meissner HP; Finn JR; Reljanovic M; Lobisch M; Schütte K; Nehrdich D; Tritschler HJ; Mehnert H; Ziegler D
    Diabet Med; 1999 Dec; 16(12):1040-3. PubMed ID: 10656234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie.
    Ziegler D; Schatz H; Conrad F; Gries FA; Ulrich H; Reichel G
    Diabetes Care; 1997 Mar; 20(3):369-73. PubMed ID: 9051389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
    El-Nahas MR; Elkannishy G; Abdelhafez H; Elkhamisy ET; El-Sehrawy AA
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1531-1534. PubMed ID: 32370731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study].
    Liu F; Zhang Y; Yang M; Liu B; Shen YD; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2706-9. PubMed ID: 18167250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
    Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
    J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
    Ziegler D; Low PA; Litchy WJ; Boulton AJ; Vinik AI; Freeman R; Samigullin R; Tritschler H; Munzel U; Maus J; Schütte K; Dyck PJ
    Diabetes Care; 2011 Sep; 34(9):2054-60. PubMed ID: 21775755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of the intravenous administration of the trometamol salt of thioctic (alpha-lipoic) acid in diabetic neuropathy].
    Strokov IA; Kozlova NA; Mozolevskiĭ IuV; Miasoedov SP; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(6):18-22. PubMed ID: 10441861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy.
    Haak E; Usadel KH; Kusterer K; Amini P; Frommeyer R; Tritschler HJ; Haak T
    Exp Clin Endocrinol Diabetes; 2000; 108(3):168-74. PubMed ID: 10926311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading.
    Garcia-Alcala H; Santos Vichido CI; Islas Macedo S; Genestier-Tamborero CN; Minutti-Palacios M; Hirales Tamez O; García C; Ziegler D
    J Diabetes Res; 2015; 2015():189857. PubMed ID: 26345602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.